PHILADELPHIA (Legal Newsline) — The U.S. Environmental Protection Agency (EPA) announced on July 13 that it reached an agreement with Jubilant Cadista Pharmaceuticals Inc. after allegations that the company had violated hazardous waste regulations at its pharmaceutical manufacturing facility in Salisbury, Md.
The EPA cited the company for violating the Resource Conservation and Recovery Act (RCRA), which is a federal rule designed to protect public health and the environment. The rule mandates how hazardous waste must be treated, stored and disposed.
Specific alleged violations include storing hazardous wastes for more than 90 days on the site, failing to properly label its waste containers, failing to keep containers closed, failing to maintain job titles and descriptions for employees dealing with the waste, failing to maintain an adequate contingency plan and failing to submit a timely and complete biennial report.
Jubilant Cadista Pharmaceuticals will pay $35,000 in penalties. The EPA noted that the company has fully complied with the case and cooperated with the agency. The company, per the settlement agreement, did not admit liability but certified its compliance with applicable RCRA requirements.